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INTRODUCTION
Reversible tyrosine phosphorylation catalysed by the opposing
actions of protein tyrosine kinases (PTKs) and protein tyrosine
phosphatases (PTPs) is a major regulatory mechanism for a
diverse number of cellular functions (for a review, see Neel and
Tonks, 1997). Although there has been a surge in the numbers
of PTPs identified in the last 5 years, relatively little is known
about the specific functions and modes of regulation of the
individual PTPs. 
The PTP Pez (PTPD2/PTP36) is a member of the subfamily
of PTPs with homology to the band 4.1 proteins, characterised
by the presence of N-terminal FERM (4.1, ezrin, radixin,
moesin) domains and C-terminal PTP catalytic domains. Other
members of the FERM subfamily of PTPs include PTPD1,
PTPH1 and PTPMeg1. Pez was first cloned in a screen for
PTPs expressed in normal breast tissue (Smith et al., 1995). It
is also expressed in varying amounts in other tissues including
kidney, skeletal muscle, lung and placenta. In human umbilical
vein endothelial cells (HUVEC), the Pez mRNA is one of the
most highly expressed PTP mRNAs (C. Wadham and Y. Khew-
Goodall, unpublished observation), suggesting it may be a
critical PTP in regulating endothelial cell function. 
The FERM superfamily of proteins include the ERM (ezrin,
radixin and moesin) proteins and talin. A feature common to
all these proteins is that they interact through their N termini
with integral plasma membrane proteins and through their C
termini with the cytoskeleton, thus forming a bridge between
the plasma membrane and the cytoskeleton (Tsukita and
Yonemura, 1997, 1999). It has been postulated that the family
of FERM proteins, particularly the ERM proteins, play a role
in organising the cytoskeleton, perhaps in response to external
cues. 
By analogy to the other members of the FERM family of
proteins, it is reasonable to predict that the FERM subfamily
of PTPs is similarly localised and perform similar functions.
Some evidence exists to support this. Ogata et al. (1999a,b)
recently demonstrated that ectopic overexpression of PTP36,
the murine homologue of Pez, led to decreases in actin stress
fibre and focal adhesions, resulting in loss of cell-matrix
adhesion and cell proliferation. They showed that ectopically
expressed PTP36 was associated with the plasma membrane
and the cytoskeletal fraction, suggesting that it may play a role
in the regulation of the cellular cytoskeleton. Studies on
PTPH1 have also shown that the N-terminal portion can
mediate associations of PTPH1 with plasma membrane
structures (Zhang et al., 1999). In addition, the FERM domain
of PTPH1 can inhibit the catalytic activity of PTPH1 in vitro
(Zhang et al., 1995), suggesting that it has functions other than
in tethering PTPH1 to the plasma membrane. Furthermore,
PTPH1 has been shown to be complexed to the adaptor
molecule 14-3-3 when it is phosphorylated (Zhang et al.,
1997), and the major substrate of PTPH1 has been identified,
using a substrate-trapping mutant of PTPH1, to be the valosin-
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Pez is a non-transmembrane tyrosine phosphatase with
homology to the FERM (4.1, ezrin, radixin, moesin) family
of proteins. The subcellular localisation of Pez in
endothelial cells was found to be regulated by cell density
and serum concentration. In confluent monolayers Pez was
cytoplasmic, but in cells cultured at low density Pez
was nuclear, suggesting that it is a nuclear protein in
proliferating cells. This notion is supported by the loss of
nuclear Pez when cells are serum-starved to induce
quiescence, and the rapid return of Pez to the nucleus upon
refeeding with serum to induce proliferation. Vascular
endothelial cells normally exist as a quiescent confluent
monolayer but become proliferative during angiogenesis or
upon vascular injury. Using a ‘wound’ assay to mimic these
events in vitro, Pez was found to be nuclear in the cells that
had migrated and were proliferative at the ‘wound’ edge.
TGFb, which inhibits cell proliferation but not migration,
inhibited the translocation of Pez to the nucleus in the cells
at the ‘wound’ edge, further strengthening the argument
that Pez plays a role in the nucleus during cell proliferation.
Together, the data presented indicate that Pez is a nuclear
tyrosine phosphatase that may play a role in cell
proliferation.
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containing protein (VCP, also known as p97/CDC48) (Zhang
et al., 1999), a protein with various potential functions
including cell-cycle regulation (Madeo et al., 1998). The
studies with PTPH1, a representative of the FERM subfamily
of PTPs, demonstrate that members of this subfamily may have
functions other than those related to cytoskeletal architecture.
In this report, we show that the subcellular localisation of
Pez is regulated. Pez is cytoplasmic in confluent monolayers
where the cells are quiescent, a state similar to the resting
endothelium lining blood vessels. However, in actively
proliferating cells growing at low cell density and in cells
induced to proliferate from the resting state by serum addition
or by the ‘wounding’ of a confluent monolayer, Pez is nuclear.
Collectively, our data demonstrate that the presence of Pez in
the nucleus correlates with cell proliferation and suggests that
it has a nuclear role during cell proliferation. In blood vessels,
the normally quiescent endothelium is induced to proliferate at
sites of vascular injury and during angiogenesis. Therefore, Pez
may play a role in regulating endothelial cell proliferation
during vascular injury and angiogenesis.
MATERIALS AND METHODS
Antibodies 
Anti-Flag epitope (M2) was obtained from AMRAD Biotech
(Victoria, Australia) and anti-ERK1/ERK2 from Zymed Laboratories
Inc. (San Francisco, CA, USA).
Generation of Pez-specific antibodies
Two peptides predicted to be immunogenic by the algorithm
‘Antigenic’ (GCG, University of Wisconsin, USA), located in the
variable region of Pez, were synthesised. The peptides,
PYTVPYGPQGVYSNKLVSPS corresponding to amino acids (aa)
495-510 (Pez495-510) and SHEVPQLPQYHHKK corresponding to aa
683-696 (Pez683-696), do not exhibit significant homology to other
proteins in the protein databases, including other members of the
FERM PTPs, suggesting that antibodies (Abs) raised against them
would be specific to Pez. The peptides were conjugated to the carrier
protein, ovalbumin (Sigma, St Louis, MO, USA) and used to
immunise rabbits. Antisera obtained against each of the peptides were
used in an ELISA to screen for binding to unconjugated peptide.
Antisera generated to Pez495-510 and Pez683-696 were called PezR1 and
PezR2, respectively. Whole antiserum to PezR1 and PezR2 were
purified using peptide affinity columns generated by coupling the
peptides Pez495-510 and Pez683-696 cross-linked to BSA to Affigel-15
(Bio-Rad Labs, Hercules, CA, USA) matrix, according to the
manufacturer’s instructions.
Western blotting, subcellular fractionation and
immunoprecipitation
For western blotting, the lysates were electrophoresed on an 8% SDS-
polyacrylamide gel (Laemmli, 1970), transferred onto Hybond-P
PVDF membranes (Amersham, Buckinghamshire, England) and
blocked with 5% milk, 0.1% Triton X-100 in phosphate-buffered
saline (PBS). Crude antisera against Pez were used at 1:500 dilution,
affinity-purified Ab were used at 1:50 or 1:100 dilution and the blots
developed using an HRP-conjugated secondary Ab (Immunotech,
Marseille, France) and enhanced chemiluminescence (Amersham).
For quantitative western blotting analysis, the blots were developed
using an alkaline phosphatase-conjugated secondary Ab, fluorescent
Vistra ECF substrates (Amersham) and the resulting band intensities
quantitated using a Fluorimager and the Imagequant software
(Molecular Dynamics). 
In studies where the Ab was preincubated with peptides prior to use
in western blots, preincubation was carried out in 1 ml PBS containing
100 m g/ml peptide for 1 hour at room temperature or overnight at 4°C. 
Total cell lysates were prepared by harvesting cells with trypsin,
followed by washing in PBS prior to lysing in Laemmli sample buffer
(Laemmli, 1970) containing 300 mM NaCl. Subcellular fractionation
into nuclear and cytoplasmic fractions was carried out according to
published protocols (Mui et al., 1995). Briefly, cells were harvested
by trypsinisation, washed in PBS and resuspended in Buffer A (50
mM Hepes, pH 7.5, 100 mM NaF, 10 mM sodium pyrophosphate, 10
mM MgCl, 2 mM sodium orthovanadate, 2 mM sodium molybdate,
2 mM EDTA, 1· protease inhibitor cocktail (Sigma)) containing 0.2%
Nonidet P-40 (Sigma) for 1 minute on ice. The nuclear pellet was
collected by a brief centrifugation for 15 seconds and washed twice
with Buffer A. The nuclear pellet was then either lysed in Laemmli
sample buffer to obtain a total nuclear fraction or resuspended in
Buffer B (50 mM Hepes, pH 7.5, 100 mM NaF, 300 mM NaCl, 10%
glycerol, 10 mM sodium pyrophosphate, 2 mM sodium
orthovanadate, 2 mM sodium molybdate, 2 mM EDTA, 1· protease
inhibitor cocktail) and rocked vigorously to obtain nuclear extract
(supernatant after centrifugation at 13000 rpm, 5 minutes at 4°C) or
nuclear pellet fraction. Immunoprecipitations were carried out by
lysing cells in RIPA buffer (50 mM Tris-HCl, 1% Nonidet P-40,
0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM
sodium orthovanadate, 1 mM sodium fluoride, 1· protease inhibitor
cocktail) followed by preclearing with protein-A sepharose beads.
Precleared lysate was incubated with antiserum for 2 hours at 4°C,
then protein-A sepharose beads were added and incubated a further 1
hour at 4°C. The protein-A sepharose complex was pelleted by
centrifugation, washed twice with RIPA buffer and boiled in Laemmli
sample buffer.
Confocal microscopy
HUVEC were plated onto fibronectin (50 m g/ml) coated glass Lab-
Tek chamber slides (Nalge Nunc International, Naperville, IL, USA)
at the indicated densities. Prior to staining, cells were fixed in 4%
paraformaldehyde/PBS for 10 minutes, quenched with 10 mg/ml
sodium borohydride for 15 minutes and then permeabilised by
treatment with 0.1% Triton X-100. Affinity-purified Ab to Pez was
used at 1:10 dilution (whole sera was used at 1:250) and indirect
immunofluorescence was detected by incubation with biotinylated
anti-rabbit secondary Ab (Rockland, Gilbertsville, PA, USA) followed
by FITC-conjugated streptavidin (Dako A/S, Denmark). Confocal
microscopy was carried out using a BioRad MRC-600 confocal
microscope. For comparison of different treatments, the laser power,
confocal aperture and contrast settings were kept constant.
Culture of primary HUVEC
HUVEC were extracted by collagenase treatment according to a
modified version of Wall et al. (1978). Cells were grown in 25 cm2
gelatin-coated tissue culture flasks (Costar, Cambridge, MA, USA) in
endotoxin-free M 199 medium (Cytosystems, Sydney, Australia)
supplemented with 20% FCS (PA Biological, Sydney, Australia), 20
mM Hepes, sodium pyruvate and non-essential amino acids at 37°C
in a 5% CO2 atmosphere. Cells were replated 2-5 days after
establishment of culture by harvesting with 0.05% trypsin-0.02%
EDTA. Endothelial cell growth supplement (Multicel, Trace
Biosystems, Australia) at 25 mg/ml and heparin were added to cells
that were passaged twice or more. In general, cells were used at first
or second passage. All reagents used in the growth and passaging of
HUVEC were made up under endotoxin-free conditions and contained
between 10-100 pg/ml endotoxin determined by the Limulus
amoebocyte assay.
Plasmids and transfection
Full-length Pez cDNA was tagged at the N terminus with the Flag-
epitope and cloned into the eukaryotic expression vector pcDNA3
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(Invitrogen, Groningen, The Netherlands). The Flag-
tagged mutant, D 4.1, was generated by deletion of amino
acids 2-336, which essentially removes the entire FERM
domain. HUVEC and 293 cells were transfected using
Lipofectamine 2000 (Life Technologies Inc., Grand
Island, NY). Cells were harvested or analysed 48 hours
after transfection.
RESULTS
Endogenous Pez expression detected by Pez-
specific antisera
Two specific antisera generated to two separate
regions of Pez were used to determine the
subcellular localisation of endogenous Pez in
primary HUVEC. Each of the antisera detected the
peptide that was used for immunisation but not the
reciprocal peptide, indicating that they are each
specific for the peptide used for immunisation (data
not shown). The single open reading frame in the
Pez cDNA sequence (Smith et al., 1995) predicted
a protein of 1187 amino acids or approximately 130
kDa. By western blotting analysis of HUVEC
lysate, each Ab (named PezR1 and PezR2) detected
two major bands, but only one major band of
approx. 130 kDa is common between the Abs and
this was not detected by the preimmune sera (Fig.
1A,C). A Flag epitope-tagged Pez ectopically
expressed in 293 cells comigrated with the 130 kDa
band from HUVEC lysate and was recognised by
PezR1, in both western blotting and
immunoprecipitation (Fig. 1B). This suggests that
the 130 kDa band from HUVEC detected by both
Abs is most likely endogenous Pez. Further
evidence that the 130 kDa band is indeed Pez is
demonstrated in Fig. 1C, where preincubating the
Abs with the peptides used for immunisation
resulted in removal of the 130 kDa band but not the
nonspecific bands. Preincubation with nonspecific
peptides had no effect. Together these data suggest
that we have generated two Pez-specific Abs that
recognise endogenous Pez.
Both the antisera were affinity-purified using the
appropriate peptide affinity columns. The resulting
affinity-purified PezR1Ab recognised only the 130
kDa Pez band (Fig. 2A) and affinity-purified PezR2
detected predominantly the 130 kDa Pez band as
well as a minor non-specific low molecular mass
band (Fig. 2B). Both the affinity-purified Abs were
subsequently used for detection of Pez by indirect
immunofluorescence. 
Endogenous Pez is nuclear or cytoplasmic
depending on cell density
The subcellular localisation of Pez in primary HUVEC was
examined by indirect immunofluorescence and confocal laser
microscopy using both the affinity-purified PezR1 and PezR2
Abs. In confluent monolayers, as predicted by the presence of
the FERM domain in the N terminus of Pez, both Abs stained
predominantly the cytoplasmic compartment (Fig. 2A,B,
confluent) and in some cells appeared to be concentrated at the
plasma membrane at intercellular junctions (data not shown).
When cells were plated sparsely, however, predominantly
nuclear staining was observed using both Abs (Fig. 2A,B,
sparse). An identical pattern of localisation was observed using
the PezR1 whole serum whereas preimmune sera or sera
preincubated with the corresponding immunising peptides
showed either no staining or greatly reduced staining,
respectively (data not shown). Because both affinity-purified
Abs (one of which, PezR1, recognised only Pez by western
blotting) showed an identical pattern of density-dependent
staining, we concluded that Pez localises to the nucleus in
sparsely plated cells but is cytoplasmic in confluent
monolayers. 
Fig. 1. Characterisation of anti-Pez antisera. (A) Western blot of HUVEC lysate
with PezR1 and PezR2 antisera. The migration of prestained markers (MW) is
shown. Each Ab recognises two major bands, of which only the 130 kDa Pez
band is common. (B) Lanes 1-3: western blot of lysates from HUVEC or 293
cells transfected with empty vector or flag-tagged Pez using the PezR1
antiserum showing ectopically expressed Pez comigrating with endogenous Pez
from HUVEC. Lanes 4 and 5: immunoprecipitation using the PezR1 antiserum
was carried out using lysates of 293 cells transfected either with empty vector or
flag-tagged Pez followed by western blotting with the anti-flag epitope Ab. 
(C) Western blot of HUVEC lysate with PezR1 (left) or PezR2 (right) antisera
that was either untreated (Nil), preincubated with the specific immunising
peptide (Pez495-510 for PezR1, Pez683-696 for PezR2) or the non-specific peptide
(Pez683-696 for PezR1, Pez495-510 for PezR2), showing that the immunising
peptide specifically blocks the Pez band. The right lane in each panel was
blotted with the appropriate preimmune serum. 
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To further verify that the nuclear staining observed by in situ
immunofluorescence microscopy was due to the presence of
Pez in the nuclear compartment, HUVEC were fractionated
into nuclear and cytoplasmic extracts and western blotted with
PezR1 Ab. The same 130 kDa band was detected in both the
nuclear and cytoplasmic fractions (Fig. 2C). The nuclear
fraction was shown to be free of cytoplasmic contamination by
the complete absence of the cytoplasmic protein MAPK
(p44Erk and p42Erk) from the nuclear fraction. Thus Pez is
indeed present in the nucleus.
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Fig. 2. Affinity purification of PezR1 and
PezR2 Abs and their use in the subcellular
localisation of endogenous Pez. (Left)
Western blots of total HUVEC lysate to
compare crude serum and affinity-purified
PezR1 and PezR2 Abs. (Middle and right)
Confocal micrographs showing indirect
immunofluorescence of HUVEC plated as
confluent (9 · 104 cells/well, middle) and
sparse (2.5 · 104 cells/well, right) monolayers
stained with either the affinity-purified PezR1
(A) or PezR2 (B) Abs. The staining with both
Abs is predominantly diffuse cytoplasmic in
the confluent monolayers and nuclear in
sparse isolated cells. (C) Western blot of total
HUVEC lysate (T) and after subcellular
fractionation into crude nuclear (N) and
cytoplasmic (C) extracts, using the PezR1
antiserum (top) and the anti-MAPK Ab
(bottom). Pez was present in both nuclear and
cytoplasmic fractions whereas the MAPK was
detectable only in the cytoplasmic fraction.
Fig. 3. Ectopically expressed Pez also localises to
both the nucleus and cytoplasm. (A) Confocal
microscopy of HUVEC transfected either with
empty vector (left) or Flag-tagged Pez (right) and
detected using the PezR1 antiserum. Pez-
overexpressing cells (amongst a background of
nontransfected cells showing endogenous Pez
staining) are denoted by arrowheads. The figures
shown are representative of at least three separate
experiments, each using a different line of
HUVEC. (B) Western blot of HEK293 nuclear
(N) and cytoplasmic (C) lysates obtained after
subcellular fractionation from cells transfected
with either empty vector, wild-type (wt) Flag-
tagged Pez or an N-terminal deletion mutant
( D 4.1). The ectopically expressed proteins were
detected with an anti-Flag epitope Ab. Nothing
was detected in the empty vector transfectants,
wt Pez was present in both the nuclear and
cytoplasmic fractions but the D 4.1 mutant was
only present in the cytoplasmic fraction.
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To determine the subcellular localisation of ectopically
expressed Pez, a Flag epitope-tagged Pez construct was
transfected into HUVEC and the cells stained with the PezR1
Ab. By indirect immunofluorescence, cells transfected with
Pez had greatly increased staining in both the nucleus and
cytoplasm compared to endogenous Pez staining in empty
vector transfected or untransfected cells (Fig. 3A). The
presence of ectopic Pez in both compartments can also be
demonstrated by western blotting following transfection into
HEK293 cells using an Ab against the Flag epitope (Fig. 3B,
wt). The presence of ectopic Pez in the nucleus cannot be
attributed solely to overexpression because a truncated form
with the N-terminal FERM domain deleted was not detected
in the nucleus (Fig. 3B, D 4.1). This further confirms that both
endogenous and ectopically expressed Pez can localise to the
nucleus and that nuclear localisation of Pez is likely to be
dependent on sequences in the FERM domain.
Similar patterns of localisation were also observed using the
PezR1 Ab in HeLa cells (data not shown), suggesting that this
pattern of compartmentalisation was not confined to HUVEC. 
Nuclear localisation of Pez is serum dependent
The above observation raised the possibility that Pez may be
nuclear in proliferating cells but cytoplasmic in cells that are
quiescent. HUVEC plated at low density were starved of serum
(0.2% FCS, 48 hours) to induce quiescence and the localisation
of Pez examined thereafter. By indirect immunofluorescence,
nuclear Pez was significantly reduced in cells made quiescent
by serum starvation but was increased following refeeding with
20% FCS for 30 minutes (Fig. 4A). To quantitate the amount
of Pez in the nucleus following serum starvation and refeeding,
nuclear and cytoplasmic fractions of cell lysates were
examined for Pez content by western blotting and

































Fig. 4. Refeeding serum-starved cells with serum increases the
fraction of Pez in the nucleus. (A) Confocal microscopy of cells
stained with PezR1 Ab showing loss of nuclear Pez in cells serum-
starved (0.2% FCS) for 48 hours and increased nuclear Pez following
refeeding with 20% FCS for 30 minutes. The figures are
representative of three separate experiments, each done in duplicate.
(B) A representative western blot detected with the PezR1 Ab (top and bottom panels) used for quantitating the proportion of Pez in the
nucleus. Serum-starved or refed cells (as in A) were fractionated into nuclear (N) and cytoplasmic (C) fractions. Lysates normalised for equal
cell numbers were loaded onto each lane. Blots were also reblotted with an anti-actin Ab (middle panel) to further control for loading. The
nonspecific band (bottom panel) is a low molecular mass nuclear protein also recognised by the PezR1 crude antiserum; it does not translocate
into the cytoplasm when cells are serum-starved. In cells treated with cycloheximide, 10 m g/ml cycloheximide was added 15 minutes prior to
refeeding with serum and left in for the entire duration of refeeding (30 minutes). (C) Quantitation of western blots carried out as described in B
using a fluorimager and the Imagequant software. Following background subtraction, the percentage of Pez in the nucleus relative to total
cellular Pez was plotted. No significant difference was observed in the percentage of nuclear Pez between refeeding in the presence or absence
of cycloheximide (CH) (P=0.44, Student’s t-test, n=2) but the percentage of nuclear Pez in refed cells compared to serum-starved cells was
significantly different (P<0.01, Student’s t-test, n=2). Inset shows quantitation of actin in the nuclear fraction relative to total cellular actin after
the blots were reprobed with an anti-actin Ab, showing that there is no significant change in the compartmentalisation of actin upon refeeding
with serum or treatment with cycloheximide. 
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remained in the nucleus after serum starvation but about 40-
50% of total Pez was back in the nucleus as rapidly as 30
minutes after refeeding with serum (Fig. 4B,C), indicating that
Pez is translocated back into the nucleus when quiscent cells
(at G0) are stimulated to proliferate upon the addition of serum.
The increase in nuclear Pez in this short period of refeeding
was unaffected by the presence of the protein synthesis
inhibitor, cycloheximide, during refeeding, suggesting that the
increase in nuclear Pez can occur in the absence of de novo
protein synthesis. In contrast to Pez, there was no significant
alteration in the proportion of actin in the nucleus when serum
was added back to the cells and this was similarly unaffected
by cycloheximide treatment (Fig. 4B,C, inset). Interestingly,
the nuclear localisation of the non-specific band also
recognised by the crude PezR1 antisera does not alter with
serum starvation (Fig. 4B, non-specific) indicating that not all
proteins translocate from the nucleus to the cytoplasm when
cells become quiescent. The presence of this nonspecific band
in the nucleus even after serum-starvation could account
for some of the residual nuclear staining detected by
immunofluorescence in Fig. 1A. We have also found that there
is no significant alteration in the amount of total Pez in the cells
after 30 minutes refeeding with serum (data not shown). 
Pez translocates into the nucleus in cells at a
‘wound’ edge
At sites of vascular injury and during angiogenesis, endothelial
cells migrate out of the intact confluent endothelium and
proliferate. To mimic these events in vitro, a confluent
monolayer of HUVEC was ‘wounded’ to generate a linear
region denuded of cells (Fig. 5A,B). The cells from the
confluent area subsequently migrate into the denuded area and
proliferate. In cells at the ‘wound’ edge that have recently
migrated into the ‘wound’, Pez is localised almost exclusively
to the nucleus whereas cells in the confluent monolayer distal
from the edge that have not migrated clearly showed Pez
remaining in the cytoplasm (similar to Fig. 2A). 
Translocation of Pez to the nucleus is inhibited by
TGF b
Because the cells at the ‘wound’ edge are both migratory and
proliferative, the role of Pez in the nucleus of these cells could
be related to either migration, proliferation or both. To
differentiate between these possibilities, cells were treated at
the time of generating the ‘wound’ with TGF b, which inhibits
proliferation by arresting cells at G1 phase (Iavarone and
Massague, 1997) but has no effect on cell migration. Following
TGF b treatment, cells at the ‘wound’edge showed little or no
increase in nuclear Pez compared to the cells in the confluent
region distal from the ‘wound’, suggesting that TGF b inhibited
the translocation of Pez into the nucleus (Fig. 5C,D). There
was no difference in the distance migrated or the number of
cells migrating into the ‘wound’ between untreated and TGF b -
treated cells, confirming that TGF b does not inhibit cell
migration (Fig. 5A,C). These data further support our earlier
observations that the translocation of Pez into the nucleus
correlates with the transition from quiescence to proliferation. 
DISCUSSION
Intracellular compartmentalisation is a powerful means of
ensuring specificity of signal transduction pathways by
limiting the access of activated, promiscuous enzymes to other
downstream partners, while increasing the efficiency of
reactions by grouping proteins involved in a particular cascade
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Fig. 5. TGFb inhibits
translocation of Pez to the
nucleus in a ‘wound’ assay.
Confocal microscopy of a
confluent monolayer of HUVEC
through which a ‘wound’ was
made by denuding a linear
region on the monolayer
followed by staining with PezR1
antiserum 17-24 hours after
‘wounding’. (A,B) Controls, no
addition. (C,D) TGF b
(0.4 ng/ml) was added at the
time the wound was made. 
(A and C) show the ‘wound’ into
which a similar degree of
cellular migration has occurred
in both control and TGF b cells.
(B and D) are higher
magnifications of the regions
marked by a vertical line in A
and C, respectively, showing
translocation of Pez into the
nucleus in the control but not
TGFb treated cells that have
migrated into the ‘wound’. The
figures are representative of
three separate experiments each
done in duplicate.
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together. Hence, the subcellular localisation of a PTP can be
an indicator of the physiological role of the PTP.
Because a number of members of the FERM family of
proteins are localised through their FERM domain to the
plasma membrane-actin cytoskeleton interface (Tsukita and
Yonemura, 1997, 1999), it was assumed that Pez would also
be similarly localised. However, this had not been
demonstrated for the endogenous protein. Using specific Abs
to Pez, we demonstrated that the nuclear or cytoplasmic
localisation of Pez was regulated by a number of factors
including cell density and the presence or absence of serum.
The presence of Pez in the nucleus of cells at low but not high
density, its absence from the nucleus of serum-starved cells and
its return to the nucleus when the cells are replenished with
serum, all suggest that Pez is a nuclear protein during cell
proliferation.
The resting endothelium that lines blood vessels is normally
nonproliferative. At sites of vascular injury and during
angiogenesis, however, endothelial cells can become migratory
and proliferative. To address whether there is an alteration in
the subcellular localisation of Pez when endothelial cells are
induced from a quiescent state to migrate and proliferate, we
used an in vitro ‘wounding’ assay to induce a small population
of endothelial cells at the ‘wound’ edge to migrate and
proliferate. Pez was indeed nuclear in the cells at the ‘wound’
edge that had migrated into the ‘wound’ but remained
cytoplasmic in the confluent cells distal from the edge. TGFb,
which inhibits cell proliferation but not migration, inhibited the
translocation of Pez to the nucleus of cells at the ‘wound’ edge,
further strengthening the argument that Pez may play a nuclear
role during cell proliferation. Although Pez is expressed in
many different cell types to varying levels, its abundance in
HUVEC suggests that it may be an important regulator of
nuclear events in endothelial cells under situations where
endothelial cell proliferation occurs.
Studies on the murine homologue of Pez, PTP36, showed
that the epitope-tagged, ectopically expressed protein used in
the studies was cytoplasmic in both HeLa cells and fibroblasts,
with no report of its presence in the nucleus (Ogata et al.,
1999a,b). We have observed, however, that Flag-epitope tagged
Pez ectopically expressed in both HUVEC (Fig. 3A) and 293
cells (Fig. 3B) was predominantly present in the nucleus in
cells at low density. The reason for the difference in subcellular
localisation between Pez and PTP36 is not immediately
obvious and requires further investigation. One reason may be
that Pez and PTP36 are isoforms rather than orthologues. A
precedence for differential localisation of isoforms of a
member of the FERM family of proteins exists: Band 4.1
protein, commonly known for its role in cross-linking the
plasma membrane of red blood cells to the spectrin
cytoskeleton, also has a nuclear isoform (Krauss et al., 1997).
The presence of Pez in the nucleus of almost all of the cells
in a low density asynchronous culture suggests that Pez is
nuclear in proliferating cells through all the stages of the cell
cycle. This remains to be confirmed by following the
subcellular localisation of Pez through the stages of the cell
cycle in synchronised cells. The data presented, taken together,
suggest that Pez translocates into the nucleus at the G0/G1
transition and moves out of the nucleus when cells enter G0.
Cell proliferation is a complex, highly coordinated process that
requires regulation of both the structural and biochemical
changes that occur. Since changes occur in the activity of many
nuclear proteins, understanding the function of Pez in the
nucleus during cell proliferation will require identification of
its nuclear substrates.
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